Loading...
Please wait, while we are loading the content...
Similar Documents
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis
| Content Provider | Scilit |
|---|---|
| Author | Frohman, Elliot M. Cutter, Gary Remington, Gina Gao, Hongjiang Rossman, Howard Weinstock-Guttman, Bianca Durfee, Jacqueline E. Conger, Amy Carl, Ellen Treadaway, Katherine Lindzen, Eric Salter, Amber Frohman, Teresa C. Shah, Anjali Bates, Angela Cox, Jennifer L. Dwyer, Michael G. Stuve, Olaf Greenberg, Benjamin M. Racke, Michael K. Zivadinov, Robert |
| Copyright Year | 2010 |
| Related Links | http://europepmc.org/articles/pmc3002613?pdf=render https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002613/pdf |
| Ending Page | 28 |
| Page Count | 14 |
| Starting Page | 15 |
| ISSN | 17562864 |
| e-ISSN | 17562864 |
| DOI | 10.1177/1756285609353354 |
| Journal | Therapeutic Advances in Neurological Disorders |
| Issue Number | 1 |
| Volume Number | 3 |
| Language | English |
| Publisher | SAGE Publications |
| Publisher Date | 2010-01-04 |
| Access Restriction | Open |
| Subject Keyword | Journal: Therapeutic Advances in Neurological Disorders Clinical Neurology Rheumatology Mri Activity Immunosuppression Interferon Beta 1a Mycophenolate Mofetil Relapsing-remitting Multiple Sclerosis |
| Content Type | Text |
| Resource Type | Article |
| Subject | Neurology Neurology (clinical) Pharmacology |